Receipt of hepatitis E vaccine and fetal loss in rural Bangladesh: further analysis of a double-blind, cluster-randomised, controlled trial.

Autor: Aziz AB; International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh; International Vaccine Institute, Seoul, South Korea; Institute of Clinical Medicine, University of Oslo, Oslo, Norway. Electronic address: asma.aziz@ivi.int., Dudman S; Institute of Clinical Medicine, University of Oslo, Oslo, Norway; Oslo University Hospital, Oslo, Norway., Julin CH; Division of Infection Control, Norwegian Institute of Public Health, Oslo, Norway., Ahmmed F; International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh., Stene-Johansen K; Division of Infection Control, Norwegian Institute of Public Health, Oslo, Norway., Sandbu S; Division of Infection Control, Norwegian Institute of Public Health, Oslo, Norway., Øverbø J; Division of Infection Control, Norwegian Institute of Public Health, Oslo, Norway., Dembinski JL; Division of Infection Control, Norwegian Institute of Public Health, Oslo, Norway., Wisløff T; Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Rana S; International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh., Basunia AH; International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh., Haque W; International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh., Qadri F; International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh., Zaman K; International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh., Clemens JD; International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh; International Vaccine Institute, Seoul, South Korea; UCLA Fielding School of Public Health, University of California, Los Angeles, CA, USA; Korea University Vaccine Innovation Center, Seoul, South Korea.

Publikováno v: The Lancet. Global health [Lancet Glob Health] 2024 Aug; Vol. 12 (8), pp. e1300-e1311.

Immunogenicity and safety of a two-dose regimen with hepatitis E virus vaccine in healthy adults in rural Bangladesh: A randomized, double-blind, controlled, phase 2/pilot trial.

Autor: Øverbø J; Norwegian Institute of Public Health, Oslo, Norway; University of Oslo, Oslo, Norway. Electronic address: joakim.overbo@fhi.no., Aziz A; University of Oslo, Oslo, Norway; International Centre for Diarrheal Diseases Research (icddr,b), Dhaka, Bangladesh; International Vaccine Institute, Seoul, Republic of Korea., Zaman K; International Centre for Diarrheal Diseases Research (icddr,b), Dhaka, Bangladesh., Clemens J; International Centre for Diarrheal Diseases Research (icddr,b), Dhaka, Bangladesh; International Vaccine Institute, Seoul, Republic of Korea; UCLA Fielding School of Public Health, Los Angeles, CA, USA., Halle Julin C; Norwegian Institute of Public Health, Oslo, Norway., Qadri F; International Centre for Diarrheal Diseases Research (icddr,b), Dhaka, Bangladesh., Stene-Johansen K; Norwegian Institute of Public Health, Oslo, Norway., Biswas R; International Centre for Diarrheal Diseases Research (icddr,b), Dhaka, Bangladesh., Islam S; International Centre for Diarrheal Diseases Research (icddr,b), Dhaka, Bangladesh., Rahman Bhuiyan T; International Centre for Diarrheal Diseases Research (icddr,b), Dhaka, Bangladesh., Haque W; International Centre for Diarrheal Diseases Research (icddr,b), Dhaka, Bangladesh., Sandbu S; Norwegian Institute of Public Health, Oslo, Norway., Elahee ME; International Centre for Diarrheal Diseases Research (icddr,b), Dhaka, Bangladesh., Ali M; Johns Hopkins University, Baltimore, MD, USA., Dembinski JL; Norwegian Institute of Public Health, Oslo, Norway., Dudman S; University of Oslo, Oslo, Norway; Oslo University Hospital, Oslo, Norway.

Publikováno v: Vaccine [Vaccine] 2023 Jan 27; Vol. 41 (5), pp. 1059-1066. Date of Electronic Publication: 2023 Jan 02.

Stability and Feasibility of Dried Blood Spots for Hepatitis E Virus Serology in a Rural Setting.

Autor: Øverbø J; Norwegian Institute of Public Health, NO-0213 Oslo, Norway.; Department of Microbiology, Institute of Clinical Medicine, University of Oslo, NO-0424 Oslo, Norway., Aziz A; Department of Microbiology, Institute of Clinical Medicine, University of Oslo, NO-0424 Oslo, Norway.; International Centre for Diarrheal Diseases Research, Dhaka 1212, Bangladesh.; International Vaccine Institute, Seoul 08826, Republic of Korea., Zaman K; International Centre for Diarrheal Diseases Research, Dhaka 1212, Bangladesh., Julin CH; Norwegian Institute of Public Health, NO-0213 Oslo, Norway., Qadri F; International Centre for Diarrheal Diseases Research, Dhaka 1212, Bangladesh., Stene-Johansen K; Norwegian Institute of Public Health, NO-0213 Oslo, Norway., Biswas R; International Centre for Diarrheal Diseases Research, Dhaka 1212, Bangladesh., Islam S; International Centre for Diarrheal Diseases Research, Dhaka 1212, Bangladesh., Bhuiyan TR; International Centre for Diarrheal Diseases Research, Dhaka 1212, Bangladesh., Haque W; International Centre for Diarrheal Diseases Research, Dhaka 1212, Bangladesh., Sandbu S; Norwegian Institute of Public Health, NO-0213 Oslo, Norway., Dembinski JL; Norwegian Institute of Public Health, NO-0213 Oslo, Norway., Dudman S; Department of Microbiology, Institute of Clinical Medicine, University of Oslo, NO-0424 Oslo, Norway.; Oslo University Hospital, NO-0424 Oslo, Norway.

Publikováno v: Viruses [Viruses] 2022 Nov 15; Vol. 14 (11). Date of Electronic Publication: 2022 Nov 15.

HEV study protocol : design of a cluster-randomised, blinded trial to assess the safety, immunogenicity and effectiveness of the hepatitis E vaccine HEV 239 (Hecolin) in women of childbearing age in rural Bangladesh.

Autor: Zaman K; International Centre for Diarhoeal Disease Resaerch, Dhaka, Bangladesh kzaman@icddrb.org., Dudman S; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Division of Infection Control and Environmental Health, Norwegian Institute of Public Health, Oslo, Norway., Stene-Johansen K; Division of Infection Control and Environmental Health, Norwegian Institute of Public Health, Oslo, Norway., Qadri F; International Centre for Diarhoeal Disease Resaerch, Dhaka, Bangladesh., Yunus M; International Centre for Diarhoeal Disease Resaerch, Dhaka, Bangladesh., Sandbu S; Division of Infection Control and Environmental Health, Norwegian Institute of Public Health, Oslo, Norway., Gurley ES; International Centre for Diarhoeal Disease Resaerch, Dhaka, Bangladesh.; Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, USA., Overbo J; Division of Infection Control and Environmental Health, Norwegian Institute of Public Health, Oslo, Norway., Julin CH; Division of Infection Control and Environmental Health, Norwegian Institute of Public Health, Oslo, Norway., Dembinski JL; Division of Infection Control and Environmental Health, Norwegian Institute of Public Health, Oslo, Norway., Nahar Q; International Centre for Diarhoeal Disease Resaerch, Dhaka, Bangladesh., Rahman A; International Centre for Diarhoeal Disease Resaerch, Dhaka, Bangladesh., Bhuiyan TR; International Centre for Diarhoeal Disease Resaerch, Dhaka, Bangladesh., Rahman M; International Centre for Diarhoeal Disease Resaerch, Dhaka, Bangladesh., Haque W; International Centre for Diarhoeal Disease Resaerch, Dhaka, Bangladesh., Khan J; International Centre for Diarhoeal Disease Resaerch, Dhaka, Bangladesh.; Health Economics, Liverpool School of Tropical Medicine, Liverpool, UK., Aziz A; International Centre for Diarhoeal Disease Resaerch, Dhaka, Bangladesh., Khanam M; International Centre for Diarhoeal Disease Resaerch, Dhaka, Bangladesh., Streatfield PK; International Centre for Diarhoeal Disease Resaerch, Dhaka, Bangladesh., Clemens JD; International Centre for Diarhoeal Disease Resaerch, Dhaka, Bangladesh.; University of California Los Angeles Jonathan and Karin Fielding School of Public Health, Los Angeles, California, USA.

Publikováno v: BMJ open [BMJ Open] 2020 Jan 19; Vol. 10 (1), pp. e033702. Date of Electronic Publication: 2020 Jan 19.

Selection and Interpretation of Scientific Evidence in Preparation for Policy Decisions: A Case Study Regarding Introduction of Rotavirus Vaccine Into National Immunization Programs in Sweden, Norway, Finland, and Denmark.

Autor: St-Martin G; Virology Surveillance and Research Unit, Statens Serum Institut, Copenhagen, Denmark., Lindstrand A; The Public Health Agency of Sweden, Stockholm, Sweden., Sandbu S; Department of Vaccine Preventable Diseases, Norwegian Institute of Public Health, Oslo, Norway., Fischer TK; Virology Surveillance and Research Unit, Statens Serum Institut, Copenhagen, Denmark.; Center for Global Health, Department of Infectious Diseases, University of Southern Denmark, Odense, Denmark.

Publikováno v: Frontiers in public health [Front Public Health] 2018 May 14; Vol. 6, pp. 131. Date of Electronic Publication: 2018 May 14 (Print Publication: 2018).